Margareta P. Correia
Porto, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Functional segregation of HIF-1α and AhR controls NK cell responsiveness under hypoxia.
Journal: iScience
Published: August 18, 2025
CAR-NK cells: harnessing the power of natural killers for advanced cancer therapy.
Journal: Frontiers in immunology
Published: March 31, 2025
Decoding MUC1 and AR axis in a radiation-induced neuroendocrine prostate cancer cell-subpopulation unveils novel therapeutic targets.
Journal: Cell death discovery
Published: January 15, 2025
Anti-tumour activity of Panobinostat in oesophageal adenocarcinoma and squamous cell carcinoma cell lines.
Journal: Clinical epigenetics
Published: April 26, 2024
Combination of MLo-1508 with sunitinib for the experimental treatment of papillary renal cell carcinoma.
Journal: Frontiers in oncology
Published: March 12, 2024
A multivalent CD44 glycoconjugate vaccine candidate for cancer immunotherapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 17, 2023
Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer.
Journal: Cell death discovery
Published: June 28, 2023
Epigenetic modulation and prostate cancer: Paving the way for NK cell anti-tumor immunity.
Journal: Frontiers in immunology
Published: January 27, 2023
Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling.
Journal: Signal transduction and targeted therapy
Published: January 23, 2023
Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?
Journal: Frontiers in molecular biosciences
Published: October 14, 2022
G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 17, 2022
Innate-like NKp30+CD8+ T cells armed with TCR/CAR target tumor heterogeneity.
Journal: Oncoimmunology
Published: January 17, 2022
Last Updated: 09/26/2026